Capsule Endoscopy - Market Insights, Competitive Landscape, and Market Forecast - 2030

Capsule Endoscopy - Market Insights, Competitive Landscape, and Market Forecast - 2030

Capsule Endoscopy Market By Product (Instrument And Accessories), End-User (Hospitals, Diagnostic Laboratories, Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of gastrointestinal disorders and technological advancement in emerging market across the globe.

The global capsule endoscopy market is estimated to grow at a CAGR of 9.61% during the forecast period from 2024 to 2030. The demand for capsule endoscopy is primarily being boosted by the growing prevalence of gastrointestinal disorders such as Chron’s disease, inflammatory bowel disease, colorectal cancer, esophageal cancer, and others. Furthermore, the capsule endoscopy market is anticipated to grow on account of a large number of ongoing improvements in product development, and technological advancement contributing to the overall growth of the capsule endoscopy market. These are some of the major drivers that are responsible for contributing to the positive growth of the capsule endoscopy market during the forecast period from 2024-2030.

Capsule Endoscopy Market Dynamics:

Based on the latest update by GLOBOCAN in 2024, it was reported that there were 1.9 million new cases of colorectal cancer in 2022. This number is expected to increase to approximately 2.36 million by the year 2030, indicating a rise in the global population affected by colorectal cancer. According to the same source, there were 538,000 new cases of colorectal cancer in Europe in 2022. It is expected that the number of cases will increase to approximately 593,000 by 2030. Thus, the increasing prevalence of colorectal cancer underscores the necessity for capsule endoscopy adoption as capsule endoscopy is used as a complementary tool for evaluating suspected colorectal lesions or abnormalities.

Moreover, the capsule endoscopy market is witnessing a significant trend driven by the increasing integration of artificial intelligence (AI) into endoscopy procedures. For instance, in October 2022, Sheba Medical Center's collaboration with Intel Corporation aimed to develop an AI algorithm capable of rapidly scanning 10,000 to 12,000 images of the digestive system within two minutes to enhance early detection of Crohn's disease. This AI algorithm, when coupled with capsule endoscopy, demonstrated high diagnostic effectiveness, boasting an impressive 86% accuracy rate in data and image analysis. Thus, the ongoing technological advancements in endoscopy procedures, facilitated by the growing integration of artificial intelligence, represent a notable trend in the capsule endoscopy future market.

Furthermore, the synergy between AI-based technology and the increasing prevalence of gastrointestinal disorders has propelled the growth of capsule endoscopy by improving diagnostic accuracy, efficiency, and accessibility, ultimately enhancing patient care and disease management in gastroenterology practice.

However, medical risks associated with capsule endoscopy and limitations related to the application of capsule endoscopy may hinder the market demand for capsule endoscopy.

Capsule Endoscopy Market Segment Analysis:

Capsule Endoscopy market by Product (Instruments and Accessories), End-User (Hospitals, Diagnostic Laboratories, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Within the capsule endoscopy market's product segment, the small bowel capsule endoscope instrument category is projected to amass a substantial revenue share by 2023. This can be attributed to the various advantages and applications provided by the small bowel capsule endoscope. Bowel capsules are primarily used to diagnose conditions affecting the small intestine, such as Crohn's disease, small bowel tumors, and other inflammatory or structural abnormalities. According to the latest data released by GLOBOCAN in 2024, approximately 1.14 million new cases of colon cancer and 730,000 new cases of rectal cancer were reported worldwide in 2022. This number is expected to increase to 1.41 million and 889,000 respectively by 2030. This data highlights the importance of small bowel capsule endoscopy and is expected to drive market growth during the forecast period.

Additionally, a small bowel capsule endoscope is a small, ingestible device used for visualizing the gastrointestinal tract, particularly the small intestine. Small bowel endoscopy techniques are minimally invasive, requiring no surgical incisions. They offer a non-invasive alternative to traditional endoscopic procedures, such as colonoscopy and upper endoscopy, and provide comprehensive visualization of the small bowel, which is often challenging to assess with conventional methods. Small bowel endoscopy can facilitate the early detection of small bowel pathologies, allowing for timely intervention and management. Early detection may lead to improved treatment outcomes, reduced complications, and better long-term prognosis for patients.

Additionally, the recent technological advancement in bowel capsule endoscopy is also playing a major role in boosting the overall market of capsule endoscopy. For instance, in January 2024, AnX Robotica announced the FDA clearance of NaviCam ProScan, the first AI-assisted reading tool designed to aid small bowel capsule endoscopy.

AnX Robotics ProScan enables physicians with the latest technology to efficiently care for their patients. Thus, healthcare providers are keen to incorporate these advanced solutions into their treatment protocols. Their focus lies on improving patient outcomes and minimizing the risk.

Overall, small bowel capsules play a valuable role in gastrointestinal diagnostics, offering patients and healthcare providers a safe, comfortable, and effective means of evaluating the small intestine for various gastrointestinal disorders.

North America Is Expected To Dominate The Overall Capsule Endoscopy Market:

North America is expected to account for the highest proportion of the capsule endoscopy market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from the prevalence of gastrointestinal disorders such as Chron’s disease, inflammatory bowel disease, colorectal cancer, and esophageal cancer.

According to the latest data provided by the American Cancer Society, in 2024 there were about 22,370 new esophageal cancer cases diagnosed in the United States of which 17,690 cases of esophageal cancer were in men and 4,680 in women. According to the latest data provided by GLOBOCAN (2024), in 2021 there were 184,000 new cases of colorectal cancer in North America. This notable prevalence underscores the significance of capsule endoscopy, as it assists healthcare providers in making informed treatment decisions for patients. Consequently, the market is influenced by the rising number of gastrointestinal cases in the region.

Additionally, the increasing agreements and collaborations of devices from leading industry companies in the United States are also playing a major role in boosting the overall future market of capsule endoscopy.

For instance, in March 2023, NexOptic Technology Corp., a Canadian technology firm focused on AI and imaging solutions, entered into a non-binding memorandum of understanding (MOU) with IntroMedic Co., Ltd., a South Korean medical device company renowned for its capsule endoscopy products. IntroMedic's MicroCam capsule endoscope offers impressive diagnostic capabilities of 12-hour operational duration and an expansive 170-degree view of the digestive tract. By joining forces with NexOptic, renowned for its artificial intelligence-driven imaging solutions, the collaboration seeks to elevate the quality of images captured during capsule endoscopy procedures, thereby improving patient outcomes. Such strategic alliances among key market players are poised to accelerate growth within the capsule endoscopy market during the projected timeframe.

Thus, this broader range of applications has contributed to increased utilization and market growth of capsule endoscopy in North America.

Capsule Endoscopy Market Key Players:

Some of the key market players operating in the capsule endoscopy include Medtronic, Olympus Corporation, Intromedic, JINSHAN Science & Technology, FUJIFILM Holdings America Corporation, CapsoCam Plus®, RF Co., Ltd., AnX Robotica, Shangxian Minimal Invasive Inc., Check-Cap, and others

Recent Developmental Activities In The Capsule Endoscopy Market:

In November 2021, Medtronic announced the clearance of 510(k) for its PillCam™ Small Bowel 3 system for remote endoscopy procedures. Medtronic's PillCam™ SB3 @HOME program merges the PillCam technology with Amazon logistics, aiming to deliver timely and precise results to patients within the comfort of their homes. This collaboration ensures an efficient process, allowing patients to undergo the procedure conveniently without the need to visit a medical facility.

In January 2021, Philips a global leader in health technology signed an agreement to acquire Capsule Technologies, Inc., a leading provider of medical device integration and data technologies for hospitals and healthcare organizations. This agreement was signed to expand the patient care management offering.

Key Takeaways From The Capsule Endoscopymarket Report Study

Market size analysis for current capsule endoscopy market size (2023), and market forecast for 6 years (2024-2030).

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.

Key companies dominating the global capsule endoscopy market.

Various opportunities available for the other competitors in the capsule endoscopy market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current capsule endoscopy market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for capsule endoscopy market growth in the coming future?

Target Audience Who Can Be Benefited From This Capsule Endoscopy Market Report Study

Capsule endoscopy product providers.

Research organizations and consulting companies.

Capsule endoscopy-related organizations, associations, forums, and other alliances.

Government and corporate offices.

Start-up companies, venture capitalists, and private equity firms.

Distributors and Traders dealing in capsule endoscopy.

Various end-users who want to know more about the capsule endoscopy market and the latest technological developments in the capsule endoscopy market.

Frequently Asked Questions For The Capsule Endoscopy Market:

1. What is Capsule endoscopy?

Capsule endoscopy is a minimally invasive diagnostic procedure used to visualize the gastrointestinal tract. During a capsule endoscopy, the patient swallows a small, pill-sized capsule containing a tiny camera, light source, and transmitter.

2. What is the market for Capsule endoscopy?

The global capsule endoscopy market is estimated to grow at a CAGR of 9.61% during the forecast period from 2024 to 2030.

3. What are the drivers for the global capsule endoscopy market?

The demand for capsule endoscopy is primarily being boosted by the growing prevalence of gastrointestinal disorders such as Chron’s disease, inflammatory bowel disease, colorectal cancer, and esophageal cancer. Furthermore, the capsule endoscopy market is anticipated to grow on account of a large number of ongoing improvements in product development, and AI-based technological advancement contributing to the overall growth of the capsule endoscopy market. These are some of the major drivers that are responsible for contributing to the positive growth of the capsule endoscopy market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Capsule Endoscopy market?

Some of the key market players operating in Capsule Endoscopy include Medtronic, Olympus Corporation, Intromedic, Jinshan Science & Technology, Fujifilm Holdings America Corporation, CapsoCam Plus®, RF Co., Ltd., AnX Robotica, Shangxian Minimal Invasive Inc., Check-Cap, and others.

5. Which region has the highest share in the global capsule endoscopy market?

North America is expected to account for the highest proportion of the capsule endoscopy market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from the prevalence of gastrointestinal disorders such as Chron’s disease, inflammatory bowel disease, colorectal cancer, esophageal cancer, and obstructive GI tract bleeding.